Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

WATER IV PCa (AS Sub-study)

NCT: NCT07650448 · NOT_YET_RECRUITING

NCT IDNCT07650448
StatusNOT_YET_RECRUITING
SponsorPROCEPT BioRobotics (INDUSTRY)
First posted
Last updated

Brief Summary

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑